Effects of short daily hemodialysis and extended standard hemodialysis on blood pressure and cardiac hypertrophy: A comparative study

Journal of Nephrology

Volumn 19, Issue 1, 2006, Pages 77-83

  Fagugli, Riccardo Maria ^a   Pasini, Paolo ^a   Pasticci, Franca ^a   Ciao, Giovanni ^a   Cicconi, Beatrice ^a   Buoncristiani, Umberto ^a  

^a Ospedale Silvestrini   (Italy)

Author keywords

Daily hemodialysis; Extended standard hemodialysis; Extracellular water hypertension; Left ventricular hypertrophy

Indexed keywords

ANTIHYPERTENSIVE AGENT; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; EXTRACELLULAR FLUID; EXTRACELLULAR SPACE; FEMALE; HEART LEFT VENTRICLE MASS; HEART VENTRICLE HYPERTROPHY; HEMODIALYSIS; HUMAN; HYPERTENSION; HYPOTENSION; IMPEDANCE; INTERMETHOD COMPARISON; KIDNEY FAILURE; LONG TERM CARE; MAINTENANCE THERAPY; MALE; SHORT COURSE THERAPY; STATISTICAL SIGNIFICANCE;

ADULT; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; PROGNOSIS; PROSPECTIVE STUDIES; RENAL DIALYSIS; TIME FACTORS;

EID: 33645468417     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Horl MP, Horl WH. Hemodialysis-associated hypertension: pathophysiology and therapy. Am J Kidney Dis 2002; 39: 227-44.
2. Fagugli RM, Pasini P, Quintaliani G, Pasticci F, Ciao G, Cicconi B, Ricciardi D, Santirosi PV, Buoncristiani E, Timio F, Valente F, Buoncristiani U. Association between extracellular water, left ventricular mass and hypertension in hemodialysis patients. Nephrol Dial Transplant 2003; 18: 2332-8.
3. Fagugli RM, Reboldi G, Quintaliani G, Pasini P, Ciao G, Cicconi D, Pasticci F, Kaufman JM, Buoncristiani U. Short daily hemodialysis: blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients. Am J Kidney Dis 2001; 38: 371-6.
4. Charra B, Chazot C, Jean G, Hurot JM, Vanel T, Terrat TC, Vo-Van C. Long 3 × 8 hr dialysis: a three-decade summary. J Nephrol 2003; 16 (suppl 7): S64-9.
5. Imai Y, Sasaki S, Minami N, Munakata M, Hashimoto J, Sakuma H, Sakuma M, Watanabe N, Imai K, Sekino H, Abe K, et al. The accuracy and performance of the A&D TM2421, a new ambulat-ory blood pressure device based on the cuff-oscillometric method and the Korotkoff sound technique. Am J Hypertens 1992; 5: 719-26.
6. Devereux RB, Reicheck N. Echocardiographic determination of left ventricular mass in men: anatomic validation of the method. Circulation 1977; 55: 613-8.
7. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 Ettropean Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-53.
8. Lukaski HC, Bolonchuk WW. Estimation of body fluid volume using tetrapolar bioelectric impedance measurements. Aviat Space Environ Med 1988; 59: 1163-9.
9. Snel YE, Brummer RJ, Doerga ME, Zelissen PM, Koppeschaar HP. Validation of extracellular water determination by bioelectric impedance analysis in growth hormone-deficient adults. Ann Nutr Metab 1995; 39: 242-50.
10. Kotler DP, Burastero S, Wang J, Pierson RN Jr. Prediction of body cell mass, fat-free mass, total body water with bioelectrical impedance analysis: effects of race, sex, and disease. Am J Clin Nutr 1996; 64 (suppl): S489-97.
11. Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE. Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease. J Am Soc Nephrol 2000; 11: 912-6.
12. Zoccali C, Benedetto A, Mallamaci F, Tripepi G, Giacone G, Stancanelli B, Cataliotti A, Malatino LS. Left ventricular monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression. Kidney Int 2004; 65: 1492-8.
13. London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, Darna B, Metivier F, Adda H, Safar ME. Alteration of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am Soc Nephrol 2001; 12: 2759-67.
14. Blumber A, Nelp WD, Hegstrom RM, Scribner BH. Extacellular volume in patients with chronic renal disease treated for hypertension by sodium restriction. Lancet 1967; 2: 69-73.
15. Özkahya M, Töz H, Ünsal A, Özerkan F, Asci G, Gürgün C, Akçiçek F, Dorhout Mees EJ. Treatment of hypertension in dialysis patients by ultrafiltration: role of cardiac dilatation and time factor. Am J Kidney Dis 1999; 34: 218-21.
16. Rahman M, Fu P, Sehgal AR, Smith MC. Interdialytic weight gain, compliance with dialysis regimen, and age are independent predictors of blood pressure in hemodialysis patients. Am J Kidney Dis 2000; 35: 257-65.
17. Chen YC, Chen HH, Yeh JC, Chen SY. Adjusting dry weight by extracellular volume and body composition in hemodialysis patients. Nephron 2002; 92: 91-6.
18. Woods JD, Port PR, Orzol S, Buoncristiani U, Young E, Wolfe RA, Held PT. Clinical and biochemical correlates of starting "daily" hemodialysis. Kidney Int 1999; 55: 2467-76.
19. Cheigh JS, Milite C, Sullivan JF, Rubin AL, Stenzel KH. Hypertension is not adequately controlled in hemodialysis patients. Am J Kidney Dis 1992; 19: 453-9.
20. Salem MM. Hypertension in the hemodialysis population: a survey of 649 patients. Am J Kidney Dis 1995; 26: 461-8.
21. Ojanen S, Koivisto AM, Koobi T, Korhonen P, Mustonen J, Laippala P, Pasternak A. Isolated ultrafiltration affects dynamic vectorcardiographic ischemia monitoring parameters. Clin Nephrol 2002; 57: 359-64.
22. Beaubien ER, Pylypchuk GB, Akhtar J, Biem HJ. Value of corrected QT interval dispersion in identifying patients initiating dialysis at increased risk of total and cardiovascular mortality. Am J Kidney Dis 2002; 39: 834-42.